viernes 4 de abril de 2025

TV

viernes 4 de abril de 2025

MATERIAL DE ARCHIVO

Russia makes progress on Sputnik-V to fight the Covid-19 pandemic

Moscow, Dec 8 (Prensa Latina) Sputnik V, the Russian vaccine to fight Covid-19, is currently advancing apace, providing positive preliminary results in the international race to get a compound that allows to immunize people and control the pandemic.

The Russian antidote has significant advantages in terms of efficiency, cost and logistics, scientists wrote on Twitter.

Some data collected from the second analysis of the third phase of clinical trials showed a 91,4% efficacy, based on 18,794 volunteers.

Some 100.000 Russians have been vaccinated so far, and the number is expected to exceed 2 million before the end of December.

The third phase of clinical trials is been also conducted in Belarus, Venezuela, the United Arab Emirates (UAE) and India.

Moscow used the emergency authorization to register its vaccines before fully completing the third phase of clinical trials; an approach that, according to its developers, other nations have been following including the United Kingdom (UK).

Unlike other proposals, Sputnik-V can be kept between two and eight degrees Celsius, and the total price of the two doses needed to vaccinate a person will be less than $20.

Over 50 countries have requested 1.2 billion doses and distribution in foreign markets will be carried out in collaboration with international partners of the Russian Fund for Direct Investment in Brazil, China, South Korea and India, among other countries.

mh/pll / mem / rbp

NOTAS RELACIONADAS
RELACIONADAS DE ARCHIVO